Cita APA

Ballinger, M. L., Osman, N., Hashimura, K., de Haan, J. B., Jandeleit-Dahm, K., Allen, T., . . . Little, P. J. (2010). Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo. Blackwell Publishing Ltd.

Citación estilo Chicago

Ballinger, Mandy L., Narin Osman, Kazuhiko Hashimura, Judy B. de Haan, Karin Jandeleit-Dahm, Terri Allen, Lisa R. Tannock, John C. Rutledge, y Peter J. Little. Imatinib Inhibits Vascular Smooth Muscle Proteoglycan Synthesis and Reduces LDL Binding in Vitro and Aortic Lipid Deposition in Vivo. Blackwell Publishing Ltd, 2010.

Cita MLA

Ballinger, Mandy L., et al. Imatinib Inhibits Vascular Smooth Muscle Proteoglycan Synthesis and Reduces LDL Binding in Vitro and Aortic Lipid Deposition in Vivo. Blackwell Publishing Ltd, 2010.